Healthcare provider profile · identity verified

Keith Edward Wright, DO

Family Practice · HANCOCK, MI · NPI 1508836719

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	442	138
Amlodipine Besylate	Amlodipine Besylate	359	109
Levothyroxine Sodium	Levothyroxine Sodium	313	88
Metoprolol Succinate	Metoprolol Succinate	281	85
Rosuvastatin Calcium	Rosuvastatin Calcium	265	84
Losartan Potassium	Losartan Potassium	264	77
Lisinopril	Lisinopril	258	79
Omeprazole	Omeprazole	225	72
Metformin Hcl	Metformin Hcl	213	64
Pantoprazole Sodium	Pantoprazole Sodium	193	60
Tamsulosin Hcl	Tamsulosin Hcl	184	61
Hydrochlorothiazide	Hydrochlorothiazide	170	51
Furosemide	Furosemide	158	49
Gabapentin	Gabapentin	151	31
Eliquis	Apixaban	139	37
Potassium Chloride	Potassium Chloride	127	43
Escitalopram Oxalate	Escitalopram Oxalate	122	31
Clopidogrel	Clopidogrel Bisulfate	109	33
Fluticasone Propionate	Fluticasone Propionate	107	44
Metoprolol Tartrate	Metoprolol Tartrate	107	38
Sertraline Hcl	Sertraline Hcl	107	33
Famotidine	Famotidine	101	33
Allopurinol	Allopurinol	100	24
Duloxetine Hcl	Duloxetine Hcl	96	27
Carvedilol	Carvedilol	91	29
Albuterol Sulfate Hfa	Albuterol Sulfate	87	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	18
Atenolol	Atenolol	66	22
Prednisone	Prednisone	65	32
Montelukast Sodium	Montelukast Sodium	64	12
Simvastatin	Simvastatin	59	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	56	13
Tramadol Hcl	Tramadol Hcl	56	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	20
Spironolactone	Spironolactone	52	18
Trazodone Hcl	Trazodone Hcl	51	14
Ezetimibe	Ezetimibe	49	15
Finasteride	Finasteride	46	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	45	13
Olmesartan Medoxomil	Olmesartan Medoxomil	45	15
Lovastatin	Lovastatin	44	12
Alendronate Sodium	Alendronate Sodium	41	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	suppressed
Xarelto	Rivaroxaban	41	11
Bupropion Xl	Bupropion Hcl	40	15
Glimepiride	Glimepiride	36	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Alprazolam	Alprazolam	33	13
Triamcinolone Acetonide	Triamcinolone Acetonide	33	21
Pravastatin Sodium	Pravastatin Sodium	31	11
Nifedipine Er	Nifedipine	29	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	29	12
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Victoza 3-Pak	Liraglutide	28	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Bumetanide	Bumetanide	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Victoza 2-Pak	Liraglutide	25	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Lorazepam	Lorazepam	23	11
Synthroid	Levothyroxine Sodium	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	13
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Baclofen	Baclofen	19	suppressed
Cephalexin	Cephalexin	19	15
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Valsartan	Valsartan	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	13
Glipizide	Glipizide	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Levoxyl	Levothyroxine Sodium	13	suppressed
Silodosin	Silodosin	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Singulair	Montelukast Sodium	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error